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Abstract
Background: HIV screening in a labour ward is the last opportunity to initiate an antiretroviral prophylaxis among pregnant
women living with HIV to prevent mother-to-child HIV transmission. Little is known about the feasibility and acceptability of HIV
screening during labour in West Africa.
Findings: A cross-sectional survey was conducted in the labour ward at the Tokoin Teaching Hospital in Lome ´ (Togo) between May
and August 2010. Pregnant women admitted for labour were randomly selected to enter the study and were interviewed on the
knowledge of their HIVstatus. Clinical and biological data were collected from the individual maternal health chart. HIV testing or
re-testing was systematically proposed to all pregnant women. Among 1530 pregnant women admitted for labour, 508 (32.2%)
were included in the study. Information on HIV screening was available in the charts of 359 women (71%). Overall, 467 women
accepted HIV testing in the labour ward (92%).The HIV prevalence was 8.8% (95% confidence interval: 6.4 to 11.7%). Among the
41 women diagnosed as living with HIV during labour, 34% had not been tested for HIV during pregnancy and were missed
opportunities. Antiretroviral prophylaxis had been initiated antenatally for 24 women living with HIV and 17 in the labour room.
Conclusions: This study is the first to show in West Africa that HIV testing in a labour room is feasible and well accepted by
pregnant women. HIV screening in labour rooms needs to be routinely implemented to reduce missed opportunities for
intervention aimed at HIV care and prevention, especially PMTCT.
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Background
Over the past two decades, considerable biomedical suc-
cesses have been achieved in the science of prevention of
mother-to-child transmission of HIV (PMTCT) in sub-Saharan
Africa. Effective interventions that can significantly reduce in
utero, intra-partum and postnatal HIV transmission are now
available [13]. Despite the increasing availability of anti-
retroviral drugs for PMTCTand the international mobilization
for the implementation of these services, the escalation of
PMTCT interventions in many countries in Africa has proved
elusive and paediatric HIV remains an uncontrolled epidemic.
In 2009, only 35% of the 125 million pregnant women in low-
and middle-income countries received an HIV test [4].
In 2010, United Nations agencies prioritized the reduction
of mother-to-child transmission of HIV, and called for its
effective elimination by 2015 [5,6]. In order to reach this
ambitious target, strategies for increasing HIV testing among
pregnant women, which is the entry point to subsequent
PMTCT interventions, are urgently needed. One such strategy
consists of HIVscreening in labour wards as recommended by
the World Health Organization (WHO), and is viewed as the
last opportunity to identify pregnant women living with
HIV and to initiate an antiretroviral prophylaxis aimed at
PMTCT [7].
The experience of HIV screening in labour wards is rarely
reported and its acceptance varies between 67 and 98%
[812]. In West Africa, the region of the world where HIV
testing coverage is the lowest (21%), there has been no
report to date on the use of this strategy.
The objectives of the study are to describe missed
opportunities for effective PMTCT interventions and to assess
the feasibility and acceptability of HIV screening in a labour
ward in a West-African setting.
Methods
A cross-sectional survey was conducted between May and
August 2010 in the labour ward of the Gynaecology Obstetrics
unit of the Tokoin Teaching Hospital in Lome ´,Togo. It was not
logistically possible to include all pregnant women admitted
for labour in this unit during the study period. All pregnant
women admitted for delivery on randomly selected days and
periods of time were systematically included in the study
(Monday from 8am to 2pm, Wednesday from 2pm to 8pm,
Saturday from 8pm to Sunday 8am).
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1Standardized forms were used to collect socio-
demographic characteristics (age, level of education, marital
status, and number of previous pregnancies) and pregnancy
history (number of antenatal visits, knowledge of HIV status,
PMTCT prophylaxis received), as well as mode of delivery,
birth outcome, and anthropometric data of the newborn.
This information was collected from maternal health records,
the delivery registry and direct interviews with the women,
which were conducted before or after delivery according to
the time of delivery.
On admission to the labour room 5 ml of venous blood
was collected from each pregnant woman. The recom-
mended national algorithm used for HIV diagnosis was:
Determine HIV-1/2 (Abbott Diagnostics) and First Response
HIV Card test 1-2.0 (PMC Medical). A woman was considered
as living with HIV when both tests were positive. In case
of no concordance of the two tests, the blood sample
was sent to the national reference laboratory for an ELISA
test.
The outcomes were:
1. Acceptance of HIV testing in a labour room.
2. Missed opportunity for HIV testing, defined as the
proportion of women who did not know their HIV
status before delivery.
3. Missed opportunity for an effective PMTCT interven-
tion defined as the proportion of women living with
HIV who did not initiate any PMTCT intervention
before delivery.
The distribution of continuous variables were compared
using the Wilcoxon rank-sum test, and comparisons between
categorical variables were performed using the Chi-square
test or Fisher’s exact test when appropriate. We estimated
the prevalence of HIV infection with its 95% confidence
interval (95% CI). Univariable and multivariable logistic re-
gressions were used. All statistical analyses were performed
with STATA†, version 9.0 (StataCorp, College Station, Texas,
USA).
The study’s protocol was approved by the National Ethic
Committee of the Ministry of Health of Togo in May 2010. All
pregnant women signed an informed consent document
before their participation in the study.
Results
Between May and August 2010, 1530 pregnant women were
admitted for delivery at the Tokoin Teaching Hospital, and
among them 508 (33.2%) were enrolled in this study. There
was no significant statistical difference between the women
included and those not included in the study (Table 1).
Median age was 27 years [inter-quartile range (IQR), 23 to 31
years], 87.8% were married or co-habiting with a partner.
Overall, 502 women (98.8%) had attended at least one
antenatal consultation before delivery: 106 (21.1%) at the
Table 1. Characteristics of pregnant women delivering at the Tokoin teaching hospital. May to August 2010, Lome ´, Togo
Included in the study, n (%)
Total, n (%) Yes No
N1530 n508 n1022 p value
Age (years)
Median (IQR) 27 (23 to 31) 26.5 (23 to 31) 27 (23 to 31) 0.819
]30 516 (33.7) 165 (32.5) 351 (34.3) 0.468
Number of pregnancies
Median (IQR) 2 (1 to 3) 2 (1 to 3) 2 (1 to 3) 0.449
1 559 (36.5) 181 (35.6) 378 (37.0) 0.650
2 to 3 660 (43.2) 217 (42.7) 443 (43.3)
]4 311 (20.3) 110 (21.7) 201 (19.7)
Mode of delivery 0.188
Vaginal 1014 (66.3) 333 (55.5) 681 (66.6)
C-section 516 (33.7) 175 (34.5) 341 (33.4)
Infant vital status 0.468
Live born 1453 (95.0) 481 (94.7) 972 (95.1)
Dead 76 (5.0) 27 (5.3) 49 (4.9)
Gender* 0.964
Boy 835 (54.5) 279 (54.5) 556 (54.4)
Girl 695 (45.4) 229 (45.5) 466 (45.6)
Birth weight (grams)*
Median (IQR) 3000 (2800 to 3300) 3000 (2750 to 3350) 3000 (2800 to 3300)
B2500g 179 (12.6) 66 (14.7) 113 (11.6) 0.101
IQR: Interquartile range.
*Only for live birth (n1420).
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2Tokoin Teaching Hospital and 396 (78.9%) at health facilities
in the periphery of Lome ´.
A total of 502 (98.8%) attended at least one antenatal visit
and among them 359 (71.5%) had information on their HIV
status reported in their individual maternal health chart.
Figure 1 shows the proportion of women diagnosed for
HIV infection during antenatal visits and in the labour ward.
Acceptance of HIV testing in the labour ward was 91.9%
(n467); 90.8% (326/359) among those tested previously
according to their antenatal record, and 94.6% (141/149)
among those tested the first time in labour ward (p0.15).
Acceptance of HIV testing in the labour ward was 91.0%
(323/355) among women who declared knowing their
HIV status and 94.1% (144/153) among those who did not
(p0.234). In univariate and multivariate analysis, none of
studied variables were associated with the acceptance of
HIV testing in the labour ward.
Overall, 467 women (91.9%) accepted HIV testing in the
labour ward and among them, 41 were living with HIV (8.8%,
95% CI: 6.4 to 11.2%). Of these 41 women living with HIV,
27 (65.9%) knew their HIV positive status already reported in
the antenatal record and 14 (34.1%) were newly diagnosed
during labour ward screening. Prevalence of HIV infection
was 8.3% (27/326) among women for whom the HIV testing
result was reported in their antenatal record, and 9.9%
(14/141) among those who were tested for the first time
(p0.56). Concordance of HIV testing between antenatal
consultation and the labour ward is reported in Table 2. In
addition to the 27 cases of HIV infection identified during
pregnancy and confirmed during labour, 14 new cases were
identified by testing in the labour ward.
Overall, 41.5% (n17) of the 41 women living with HIV
had not initiated any PMTCT intervention antenatally. In
multivariate analysis, the missed opportunities for antenatal
PMTCT interventions were associated with gravidity ]2
(adjusted Odds Ratio [aOR], 2.07; 95% CI: 1.29 to 3.33), not
being married (aOR, 1.82; 95% CI: 1.00 to 3.23), and having
made antenatal visits at health facilities in the periphery of
Lome ´ (aOR, 3.57; 95% CI: 1.96 to 6.67). Among the 27
pregnant women who knew their status HIV antenatally, two
had initiated antiretroviral therapy for their own health, 22
received zidovudine and a single-dose of nevirapine and
three did not initiate any antiretroviral intervention before
their admission to the labour ward. Among the 14 women
living with HIV diagnosed in labour room, all of them
received an antiretroviral prophylaxis during labour.
Discussion
In this study carried out in the obstetrical ward at the
Tokoin Teaching Hospital, which is the biggest referral health
centre for delivery in Togo, we found that 92% of pregnant
women agreed to be tested for HIV in the labour room. HIV
prevalence in the labour room in this referral centre was
8.8% and the 14 newly diagnosed women (34% of the total)
initiated antiretroviral prophylaxis.
In 2004, HIV testing in labour rooms was recommended by
the US Centers Diseases for Control and Prevention [13] and
in 2010, WHO recommended that in the countries where
HIV epidemic is considered generalized (prevalence  1% in
pregnant women) there should be HIV retesting in all HIV-
negative or HIV status unknown women at the time of
delivery [7]. The rationale to focus on HIV testing in the
labour ward in a country such as Togo, which has an HIV
testing coverage in pregnant women estimated at 18%, is the
fact that this strategy is the last opportunity to introduce an
antiretroviral prophylaxis for PMTCT in order to reduce the
many missed opportunities for intervention [5,7,14,15].
Figure 1. Proportion of women screened for HIV infection during antenatal visits and in delivery ward. May to August 2010, Lome ´, Togo.
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3The acceptance of HIV testing in the labour room was
relatively higher than the percentage reported in a study in
Zambia where 67% of 217 women accepted to undergo HIV
testing [10]. Elsewhere, the acceptance rate was 98% in a
University hospital located in rural India [12] and 85% in a US
trial [9]. Overall, these studies, including ours, show that HIV
testing is highly feasible and acceptable even in busy delivery
wards. The key factor that may influence the acceptance of
HIV testing in labour wards is the type of HIV test used. Oral
fluid-based rapid HIV tests seem more convenient and do not
elicit patients’ fear of blood draw (as reported in India).
The lack of dedicated staff for this procedure is another
concern. Indeed, in the US study, low acceptance of HIV
testing during the night shift was reported because of limited
staff availability [9]. In our study, 29% of pregnant women,
despite having had antenatal care visits did not know their
HIV status before entering the labour ward. This figure
decreased to 1.6% after introducing HIV testing in the labour
room. Therefore, as already supported by international
guidelines, it is of the utmost importance to place standing
orders in all labour rooms in sub-Sahara Africa to inform
every woman that she will be tested unless she states
otherwise [13].
During this study, we faced some challenges. Firstly, the
duration of pre-test counselling was short, on average 3
minutes, which was close to the duration of the individual
pre-test counselling in African settings [14]. Secondly, the
understanding of the message about HIV testing during
labour was a concern, but we were unable to document it in
this study. Finally, the team discussed case by case whether
they would postpone HIV testing until after delivery in order
to ensure that patients were not coerced into HIV testing
during labour.
The prevalence of HIV among pregnant women admitted
for delivery was estimated at 8.8%, more than twice the HIV
prevalence reported in pregnant women in Togo in 2009
(3.9%) and very close to the HIV prevalence reported in
Lome ´, the capital of Togo (6.3%). The site selected for
this study which is the reference centre located at the
teaching hospital could explain the higher prevalence figure
observed.
Among the 41 women identified as living with HIV in the
labour ward, 17 (34%) did not know their HIV status before
being admitted to the labour ward and the testing procedure
allowed the immediate initiation of ARV prophylaxis to all of
them. In rural India in 2007, 11 out of 15 women living with
HIV (73%) learnt of their HIV status in the delivery room [12].
In the absence of ARV intervention in breastfeeding popula-
tions between 30 and 40% of pregnant women living with
HIV transmit HIV to their infant [3]. According to the study
reported in Malawi, which included HIV-exposed infants
whose mothers did not receive antiretroviral prophylaxis,
the rate of HIV transmission was 15.5% at eight weeks of life
in children who received zidovudinesingle-dose nevira-
pine, a 50% reduction compared to no intervention [15].
This study has some limitations. First, it was conducted in a
single labour ward and specifically in a referral centre.
Therefore, our sample is not representative of all pregnant
women in Togo, limiting the generalization of the findings to
the rest of the country. Second, the choice to propose an
antiretroviral prophylaxis to newly diagnosed pregnant
women living with HIV was part of the project intervention
and an anonymous cord blood-surveillance strategy was not
used to measure PMTCT coverage as done previously in the
PEARL survey [14]. Despite these limitations, this is to our
knowledge the first study conducted in the largest delivery
ward in Togo and the first one evaluating the feasibility and
acceptance of HIV testing during labour in West Africa. Since
only 1.2% women refused HIV testing, the HIV prevalence
estimate is very close to the true prevalence in pregnant
women attending this hospital.
Conclusions
In conclusion, HIV testing in the labour room is highly feasible
and acceptable and can significantly reduce missed oppor-
tunities for effective PMTCT interventions. The implementa-
tion of this strategy should be put in place in all maternity
hospitals and the dedicated staff should be trained for this
procedure as well. However, involuntary testing is a potential
challenge to implementing provider initiating testing strategy
in the labour ward. This salvage intervention for PMTCT will
increase the PMTCT coverage which remains low in sub-
Saharan Africa and will help to will reinforce the linkage for
early infant diagnosis. In the context of virtual elimination
of MTCT by 2015, there is no doubt that this strategy is
extremely relevant.
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Table 2. Concordance of HIV testing between antenatal
consultation and delivery ward, n (%). May to August 2010,
Lome ´, Togo
HIV testing in delivery ward
Positive Negative Refusal
N (%) N (%) N (%) Total
HIV testing in antenatal consultation*
Positive 27 (100.0) 0 0 27 (100.0)
Negative 0 299 (90.1) 33 (9.9) 332 (100.0)
Not done or not
reported
14 (9.4) 127 (85.2) 8 (5.4) 149 (100.0)
Total 41 426 41 508 (100.0)
*Based on HIV testing information reported in the maternal health
chart.
Percentages represent the proportion of women on line.
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